亚虎体育登录首页是最具公信力品牌,以真人视讯;电子游戏及体育赛事等百种游戏深受玩家喜爱,亚虎体育登录首页成为亚洲最受欢迎的线上娱乐平台.

    1. <meter id="4q3tn"></meter>
      <cite id="4q3tn"><delect id="4q3tn"><video id="4q3tn"></video></delect></cite>

      <s id="4q3tn"><nav id="4q3tn"><cite id="4q3tn"></cite></nav></s>

    2. <form id="4q3tn"><delect id="4q3tn"></delect></form>

    3. <s id="4q3tn"><b id="4q3tn"></b></s>
      <code id="4q3tn"><xmp id="4q3tn"></xmp></code>
      <cite id="4q3tn"><li id="4q3tn"><wbr id="4q3tn"></wbr></li></cite>
      <tt id="4q3tn"><li id="4q3tn"></li></tt>
    4. <tbody id="4q3tn"><label id="4q3tn"><td id="4q3tn"></td></label></tbody>
      <noscript id="4q3tn"><var id="4q3tn"><wbr id="4q3tn"></wbr></var></noscript>
      Ameining (agomelatine tablets)
      agomelatine tablets

      English Name: Agomelatine Tablets
      Chinese Pinyin: Agemeilating Pian

      The active pharmaceutical ingredient is Agomelatine

      Chemical Name:N-[2- (7-methoxy-1- naphthyl) ethyl] acetamide


      /en/upload/images/2017/06/06/19dbadc740e34c29b193395ff2c6bb46.png
      【Name】

      Common Name: Agomelatine Tablets
      English Name: Agomelatine Tablets
      Chinese Pinyin: Agemeilating Pian

      【Ingredient】

      The active pharmaceutical ingredient is Agomelatine

      Chemical Name:N-[2- (7-methoxy-1- naphthyl) ethyl] acetamide

      Chemical Structure:

      Molecular Formula:C15H17NO2

      Molecular Weight:243.3

      【Description】

      This product is a film-coated tablet, presenting white or off-white after removal of the coating.

      【Indication】

      Adult depression treatment.

      Agomelatine is indicated for adults.

      【Strength】 25 mg。
      【Dosage and Administration】

      Dosage

      The recommended dose is 25 mg once daily taken orally at bedtime.

      If there is no improvement of symptoms after two weeks of treatment, the dose may be increased the dose to 50 mg once daily, i.e. two 25 mg tablets, taken together before bedtime.

      Decision of dose increase has to be balanced with a higher risk of transaminases elevation. Any dose increase to 50 mg should be made on an individual patient benefit/risk basis and strict respect of LFT monitoring..

      Liver fuction tests should be performed in all patients before starting treatment. During treatment LFTshould be monitored periodicallyafter around 3 weeks, 6 weeks (end of the acute phase), 12 weeks, and 24 weeks (end of the maintenance phase). Thereafter, liver function could be tested according to clinical needs (see [Precautions]).

      When increasing the dosage, the liver function tests should be performed again at the same frequency as when initiating treatment.
      Treatment duration

      Patients with depression should be treated for a sufficient period (at least 6 months) to ensure they are free of symptoms.

      Treatment Discontinuation

      No dosage tapering is needed on treatment discontinuation.

      Method of Administration

      For oral use

      Agomelatine tablets may be taken with food or on an empty stomach.

      Special populations

      Renal impairment:

      No relevant modification in agomelatine pharmacokinetic parameters in patients with severe renal impairment has been observed. However,  only limited clinical data on the use of Agomelatine in depressed patients with moderate/severe renal impairment is available. Therefore, caution should be exercised when prescribing agomelatin to thes patients.

      Liver function impairment:

      Agomelatine is contraindicated in hepatitis B virus carriers/patients, hepatitis C virus carriers/patients, and liver function impairment patients (see [Contraindications] [Precautions] and [Pharmacokinetics]).

      2014: First-to-market generic drug in China

      2017: Included in NRDL


      *
      *
      *
      * Click image refresh
      亚虎体育登录首页
      1. <meter id="4q3tn"></meter>
        <cite id="4q3tn"><delect id="4q3tn"><video id="4q3tn"></video></delect></cite>

        <s id="4q3tn"><nav id="4q3tn"><cite id="4q3tn"></cite></nav></s>

      2. <form id="4q3tn"><delect id="4q3tn"></delect></form>

      3. <s id="4q3tn"><b id="4q3tn"></b></s>
        <code id="4q3tn"><xmp id="4q3tn"></xmp></code>
        <cite id="4q3tn"><li id="4q3tn"><wbr id="4q3tn"></wbr></li></cite>
        <tt id="4q3tn"><li id="4q3tn"></li></tt>
      4. <tbody id="4q3tn"><label id="4q3tn"><td id="4q3tn"></td></label></tbody>
        <noscript id="4q3tn"><var id="4q3tn"><wbr id="4q3tn"></wbr></var></noscript>